Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2026 – November 2026 · 2 captures · latest observed messagingResponse is the ultimate biomarker
Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma, transforming patient biopsies into miniaturized tumor avatars
10 July 2026 · Response is the ultimate biomarkerarchived page
6 November 2026 · Response is the ultimate biomarkercurrent websiteHistorical capture not publicly available
January 2024 – January 2025 · 3 capturesAutomated 3D organoid screening technology
Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy,